KMT2A and thyroid gland carcinoma: Interestingly, we found that expression of MLL1 is reduced in most solid tumors including bladder, breast, prostate, lung, and thyroid cancers compared with the expression in corresponding normal tissues (P < 0.001) (Fig. 2B).